$44.04
3M Ago | 1M Ago | Current | |
Buy | 10 | 10 | 10 |
Outperform | 5 | 5 | 6 |
Hold | 6 | 7 | 7 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
The latest share price target for Kymera Therapeutics Inc (KYMR) is $51.43, offered by 23 analysts offering 12-month price forecasts.
Kymera Therapeutics Inc (KYMR) has a maximum of 0.17 upside potential, based on 23 analysts offering 12-month price forecasts.
Based on 23 analysts tracking and researching Kymera Therapeutics Inc (KYMR), 69.57% have a buy recommendation. Remaining 30.43% have either sell or hold recommendations.
The latest share price of Kymera Therapeutics Inc (KYMR) is $44.04 as of 26/07/2024.
16 of total 23 analysts offering stock ratings for Kymera Therapeutics Inc KYMR have recommended buy rating.